Stay informed with the latest litigation news. Explore now

IP Verse

Otsuka Pharmaceutical competitive analysis

Latest publications and patents of Otsuka Pharmaceutical New

Explore the latest publications and patents granted to Otsuka Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Otsuka Pharmaceutical

EP2767285
Feb 19, 2025Tablet Including 7-[4-(4-Benzo[Beta]Thiophen-4-Yl-Piperazin-1-Yl) Butoxy]-1H-Quinolin-2-One Or Salt ThereofPatent Maintained As Amended
EP4125903
Oct 9, 2024Methods For Dose Initiation Of Aripiprazole TreatmentsGranted And Under Opposition
EP4069254
Sep 11, 2024Combination Decitabine And Cedazuridine Solid Oral Dosage FormsGranted And Under Opposition
EP2841431
Jan 24, 2024Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The SamePatent Maintained As Amended
EP2841054
Apr 6, 2022Injectable PreparationPatent Maintained As Amended
EP2868318
Jan 26, 2022Injectable FormulationPatent Maintained As Amended
EP2667856
Dec 1, 2021Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active IngredientGranted And Under Opposition
EP2612653
Jun 9, 2021Composition For Cleaning Scalp And Head HairPatent Maintained As Amended
EP2783689
Sep 25, 2019Keratoconjunctival Protecting Agent, Or Keratoconjunctival Disorder Inhibiting AgentOpposition Rejected
EP2548608
Jan 31, 2018Proteoglycan-Containing Microneedle ArrayNo Opposition Filed Within Time Limit

Latest patents of Otsuka Pharmaceutical opposed by its competitors

Explore Otsuka Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2767285
Feb 19, 2025Tablet Including 7-[4-(4-Benzo[Beta]Thiophen-4-Yl-Piperazin-1-Yl) Butoxy]-1H-Quinolin-2-One Or Salt Thereof2
EP4125903
Oct 9, 2024Methods For Dose Initiation Of Aripiprazole Treatments7
EP4069254
Sep 11, 2024Combination Decitabine And Cedazuridine Solid Oral Dosage Forms1
EP2841431
Jan 24, 2024Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same1
EP2841054
Apr 6, 2022Injectable Preparation1
EP2868318
Jan 26, 2022Injectable Formulation1
EP2667856
Dec 1, 2021Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active Ingredient4
EP2612653
Jun 9, 2021Composition For Cleaning Scalp And Head Hair1
EP2783689
Sep 25, 2019Keratoconjunctival Protecting Agent, Or Keratoconjunctival Disorder Inhibiting Agent1
EP2694043
Nov 1, 2017Combinations Comprising Brexpiprazole Or A Salt Thereof And A Second Drug For Use In The Treatment Of A Cns Disorder2

Latest PTAB cases involving Otsuka Pharmaceutical New

Discover the latest PTAB cases involving Otsuka Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Otsuka Pharmaceutical

IPR2017-00287Nov 17, 2016ALKERMES PHARMA IRELANDOTSUKA PHARMACEUTICALInstitution Denied

Top competitors of Otsuka Pharmaceutical

Top competitors of Otsuka Pharmaceutical based on patent oppositions.